LEWISTON — Nominations are now being accepted for the Amgen Breakaway from Cancer Survivor Award. Amgen, the title sponsor of the annual Dempsey Challenge, will present the award during Dempsey Challenge weekend on Oct. 13 and 14.
The criteria for nominees is as follows:
— Individual is a cancer survivor
— Individual lives and/or “helps others” in the Central Maine region
— Individual demonstrates passion for helping others diagnosed with cancer
— Individual is actively involved in community outreach
— Individual inspires others by a demonstrated passion
“Amgen created Breakaway from Cancer in 2005 with a mission to help connect cancer patients and their loved ones to support and resources, like those offered by the Dempsey Center,” Bob Azelby, vice president and general manager of Amgen Oncology, said in a news release.
The winner will play a significant role during the event weekend including sharing his or her story during opening ceremonies, leading cancer survivors and caregivers in the Amgen Breakaway from Cancer Survivor Walk and addressing top fundraisers and special guests at the Champions for Hope celebration.
“The Breakaway from Cancer Survivor Award recognizes the importance of survivors sharing their stories and strength with others who are impacted by cancer,” Aimee Arsenault, Dempsey Challenge event manager said in a news release. “Thanks to Amgen, we are able to honor these special individuals who work toward a goal that’s shared by the Dempsey Challenge — ensuring that no one is alone in their cancer journey.”
Nominations will be accepted until Friday.
For more information or to submit a nomination, fax to 755-5872, visit www.dempseychallenge.org, or mail to Samantha Brooks c/o Central Maine Medical Center, 300 Main St., Lewiston, ME 04240.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less